Parliament Tells PM To Take 'All Necessary Steps' To Keep UK In EMA After Brexit
Executive Summary
Members of parliament in the UK want the government to take "all necessary steps" to keep the country in the EU medicines regulatory network after Brexit. It's not that easy, though.
You may also be interested in...
Restless Summer For Brexit Officials – Both Sides Of The EU Divide
UK Brexit officials have been making positive noises at last about the proposals in the hoped-for trade deal that the UK is seeking for the post-EU period after March 29, 2019. But experience shows that the only certainty in Brexit is uncertainty, meaning several busy weeks ahead for those hammering out a UK-EU trade deal.
Long-Awaited Brexit White Paper Lays Out UK’s Plans For Medicines Regulation
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
EU Accelerated Assessment Tracker
Marinus’s ganaxolone has lost its accelerated assessment status mid-review at the European Medicines Agency while Roche’s glofitamab will be fast-tracked once a filing has been made.